AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene ATP6V0E1andSNORA74B.
, go to our main page or see our latest news
Homo sapiens complex locus ATP6V0E1andSNORA74B, encoding ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 and small nucleolar RNA, H/ACA box 74B.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 331 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in pancreas (seen 40 times), breast carcinoma (34), eye (21), lung (20), purified pancreatic islet (19), placenta (18), skin (18), insulinoma (14), prostate (14), placenta cot 25-normalized (13), breast (12), ovary (12), brain (10), kidney (8), RPE and choroid (8), uterus (8), melanotic melanoma, cell line (6), bone (5), colon (5), adenocarcinoma (4), chondrosarcoma lung metastasis cell lines (4), heart (4), melanotic melanoma (4), papillary serous carcinoma (4), amelanotic melanoma, cell line (3), aorta (3), epithelioid carcinoma (3), hypothalamus (3), large cell carcinoma (3), medulla (3), retinoblastoma (3), stomach (3), teratocarcinoma, cell line (3), 2 pooled tumors (clear cell type) (2), B cells from burkitt lymphoma (2), beard hair (2), blood (2), breast normal (2), carcinoid (2), carcinoma, cell line (2), ductal carcinoma, cell line (2), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (2), epithelioid carcinoma cell line (2), eyeball (2), fetal eyes (2), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (2), fibrotheoma (2), germinal center B cell (2), hip (2), leiomios (2), leiomyosarcoma (2), liver (2), liver and spleen (2), lymph (2), lymphoma, cell line (2), melanocyte (2), occipital scalp hair (2), oligodendroglioma (2), optic nerve (2), subchondral bone (2), testis normal (2), adenocarcinoma cell line (once), adrenal gland (once), alveolar macrophage (once), B cells (ramos cell line) cot 25-normalized (once), bone marrow (once), breast, tumor tissue (once), chondrosarcoma (once), cochlea (once), colon ins (once), cornea (once), ear (once), embryonal carcinoma (once), embryonal kidney (once), embryonic stem cells, dmso-treated H9 cellline (once), embryonic stem cells, WA01, passage 38 (once), epidermoid carcinoma, cell line (once), esophagus (once), eye anterior segment (once), germ cell tumor (once), head neck (once), hippocampus (once), hypernephroma, cell line (once), invasive adenocarcinoma (once), invasive carcinoma (once), knee (once), left pubic bone (once), lung focal fibrosis (once), lung tumor (once), lymphocyte (once), mammary adenocarcinoma, cell line (once), marrow (once), medullary carcinoma (once), melanotic melanoma, high MDR (once), moderate to poorly differentiated invasivecarcinoma (once), nervous tumor (once), neuroblastoma (once), normal nasopharynx (once), normal pigmented retinal epithelium (once), osteoarthritic cartilage (once), osteosarcoma, cell line (once), pericardium (once), pituitary (once), pooled colon, kidney, stomach (once), pre-eclamptic placenta (once), primary lung epithelial cells (once), prostate tumor (once), salivary gland (once), small cell carcinoma (once), squamous cell carcinoma (once), squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) (once), stem cell 34+/38+ (once), stomach normal (once), t-lymphocytes (once), testis (once), three pooled meningiomas (once), thyroid (once), thyroid gland (once), tongue (once), tumor, 5 pooled (see description) (once), uterus tumor (once), whole embryo, mainly body (once).
331 cDNA clones support the 7 variants of gene ATP6V0E1andSNORA74B
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
CR977920 | T-Lymphocytes | .a-u | 1 to 615 | 1 to 616 | F63S R64G G65E I66F S68L ... | tiling clone, | | 616/617 (99 %) | 7 diff (98.9 %id) |
BU954807 | mixed (pool of 40 RNAs) | .b | 1 to 505 | 1 to 512 | exact | tiling clone, | | 512/868 (58 %) | 29 diff (96.7 %id) |
BF691381 | melanotic melanoma, high MDR, skin | .c | 1 to 759 | 1 to 759 | exact | tiling clone, | | 759/798 (95 %) | 12 diff (98.5 %id) |
NM_003945.3 | | .c | 1 to 882 | 1 to 882 | exact | RefSeq, AAA | | 882/882 (100 %) | 0 diff (100 %id) |
FN175556 | breast carcinoma | .c | 8 to 81 | 1 to 73 | | | | 73/80 (91 %) | 4 diff (95.0 %id) |
BF093260 | testis_normal | .c | 10 to 448 | 439 to 1 | exact | | | 439/442 (99 %) | 7 diff (98.5 %id) |
BG572771 | placenta | .c | 12 to 742 | 1 to 727 | exact | | | 727/727 (100 %) | 4 diff (99.5 %id) |
BG623204 | placenta | .c | 12 to 868 | 1 to 865 | exact | | | 865/901 (96 %) | 28 diff (96.9 %id) |
BP366360 | | .c | 12 to 593 | 1 to 582 | exact | | | 582/582 (100 %) | 0 diff (100 %id) |
BM474319 | leiomyosarcoma, uterus | .c | 13 to 853 | 1 to 841 | exact | | | 841/1013 (83 %) | 36 diff (96.5 %id) |
BF802704 | colon_ins | .c | 15 to 571 | 557 to 2 | exact | | Submitted on the opposite strand | 556/557 (99 %) | 1 diff (99.9 %id) |
BC119715 | PCR rescued clones | .c | 21 to 531 | 1 to 511 | exact | | | 511/511 (100 %) | 0 diff (100 %id) |
BU949847 | Pancreas, Purified pancreatic islet | .c | 24 to 514 | 1 to 491 | exact | fully sequenced, | | 491/491 (100 %) | 2 diff (99.6 %id) |
BP316637 | pericardium | .c | 25 to 607 | 1 to 583 | exact | | | 583/583 (100 %) | 0 diff (100 %id) |
BC119714 | PCR rescued clones | .c | 26 to 531 | 1 to 506 | exact | | | 506/506 (100 %) | 0 diff (100 %id) |
BG505630 | embryonal carcinoma, testis | .c | 26 to 877 | 1 to 863 | exact | | | 863/985 (87 %) | 48 diff (95.2 %id) |
AW749064 | breast | .c | 28 to 252 | 282 to 54 | | | | 229/283 (80 %) | 9 diff (96.9 %id) |
EL954374 | eyeball | .c | 28 to 502 | 1 to 475 | L41* | | | 475/475 (100 %) | 11 diff (97.7 %id) |
BQ668455 | epidermoid carcinoma, cell line, salivary gland | .c | 28 to 877 | 14 to 864 | exact | | | 851/1032 (82 %) | 16 diff (98.5 %id) |
N57319 | placenta | .c | 29 to 379 | 1 to 349 | exact | | | 349/349 (100 %) | 2 diff (99.5 %id) |
BQ269493 | Pancreas, Purified pancreatic islet | .c | 31 to 529 | 1 to 499 | exact | fully sequenced, | | 499/499 (100 %) | 2 diff (99.6 %id) |
CD048034 | embryonic stem cells, WA01, passage 38 | .c | 32 to 834 | 23 to 831 | exact | | | 809/863 (93 %) | 15 diff (98.3 %id) |
FN103746 | breast carcinoma | .c | 32 to 112 | 1 to 79 | | | | 79/83 (95 %) | 5 diff (94.0 %id) |
CF128347 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 34 to 848 | 1 to 812 | exact | | | 812/816 (99 %) | 8 diff (99.1 %id) |
BM708048 | eye, RPE and Choroid | .c | 34 to 513 | 1 to 480 | exact | | | 480/480 (100 %) | 0 diff (100 %id) |
BU952198 | Pancreas, Purified pancreatic islet | .c | 36 to 514 | 1 to 479 | A58F | fully sequenced, | | 479/479 (100 %) | 2 diff (99.6 %id) |
TI_154194207 | | .c | 36 to 873 | 48 to 880 | exact | | | 833/1049 (79 %) | 14 diff (98.7 %id) |
AK312068 | | .c | 37 to 347 | 1 to 311 | exact | | | 311/311 (100 %) | 1 diff (99.7 %id) |
FN149060 | breast carcinoma | .c | 37 to 119 | 1 to 83 | | | | 83/83 (100 %) | 3 diff (96.4 %id) |
DB489268 | hypothalamus | .c | 37 to 717 | 1 to 680 | exact | | | 680/681 (99 %) | 3 diff (99.6 %id) |
DA556259 | | .c | 38 to 514 | 2 to 478 | exact | capped | | 477/477 (100 %) | 0 diff (100 %id) |
BI601240 | brain, hypothalamus | .c | 38 to 880 | 1 to 851 | exact | | | 851/866 (98 %) | 19 diff (97.9 %id) |
DA885426 | | .c | 38 to 585 | 2 to 549 | exact | capped | | 548/548 (100 %) | 0 diff (100 %id) |
DB003163 | breast, tumor tissue | .c | 38 to 576 | 2 to 540 | exact | capped | | 539/539 (100 %) | 0 diff (100 %id) |
DB285933 | uterus | .c | 38 to 572 | 2 to 536 | exact | capped | | 535/535 (100 %) | 0 diff (100 %id) |
BG436165 | placenta | .c | 39 to 822 | 1 to 786 | exact | | | 786/786 (100 %) | 22 diff (97.3 %id) |
BU942892 | mixed (pool of 40 RNAs) | .c | 39 to 846 | 1 to 813 | exact | | | 813/814 (99 %) | 18 diff (97.8 %id) |
CD692055 | normal nasopharynx | .c | 40 to 691 | 23 to 674 | exact | | | 652/674 (96 %) | 6 diff (99.2 %id) |
ES307726 | beard hair, skin | .c | 40 to 201 | 1 to 162 | | | | 162/162 (100 %) | 0 diff (100 %id) |
BP258567 | heart | .c | 40 to 622 | 1 to 583 | exact | | | 583/583 (100 %) | 0 diff (100 %id) |
CB110722 | Liver | .c | 40 to 609 | 1 to 570 | exact | | | 570/570 (100 %) | 0 diff (100 %id) |
Y15286 | placenta | .c | 40 to 875 | 1 to 836 | exact | | | 836/836 (100 %) | 0 diff (100 %id) |
BU952131 | Pancreas, Purified pancreatic islet | .c | 41 to 515 | 1 to 477 | A58F Q59L L60N N61S P62T ... | fully sequenced, | | 477/477 (100 %) | 4 diff (99.2 %id) |
BP301545 | | .c | 41 to 623 | 1 to 583 | exact | | | 583/583 (100 %) | 0 diff (100 %id) |
CB995436 | placenta, pre-eclamptic placenta | .c | 43 to 815 | 28 to 803 | exact | | | 776/819 (94 %) | 19 diff (97.7 %id) |
TI_45211269 | | .c | 43 to 880 | 129 to 974 | exact | | | 846/989 (85 %) | 20 diff (98.0 %id) |
TI_57149980 | | .c | 45 to 882 | 32 to 869 | exact | | | 838/950 (88 %) | 13 diff (98.7 %id) |
TI_45215833 | | .c | 50 to 877 | 93 to 931 | exact | | | 839/941 (89 %) | 33 diff (96.5 %id) |
TI_57187446 | | .c | 50 to 824 | 53 to 825 | exact | | | 773/773 (100 %) | 4 diff (99.5 %id) |
BI857480 | breast, mammary adenocarcinoma, cell line | .c | 51 to 824 | 1 to 772 | exact | | | 772/772 (100 %) | 4 diff (99.5 %id) |
BQ957835 | carcinoma, cell line, Prostate | .c | 52 to 875 | 1 to 825 | exact | AAA | | 825/825 (100 %) | 4 diff (99.6 %id) |
BM690381 | eye, RPE and Choroid | .c | 52 to 714 | 1 to 663 | exact | | | 663/663 (100 %) | 5 diff (99.3 %id) |
CR594596 | B cells (Ramos cell line) Cot 25-normalized | .c | 53 to 871 | 1 to 819 | exact | | | 819/819 (100 %) | 0 diff (100 %id) |
CR599928 | Placenta Cot 25-normalized | .c | 53 to 877 | 1 to 825 | exact | | | 825/825 (100 %) | 0 diff (100 %id) |
CR613914 | Placenta Cot 25-normalized | .c | 53 to 877 | 1 to 825 | exact | | | 825/825 (100 %) | 0 diff (100 %id) |
CR617216 | neuroblastoma | .c | 53 to 877 | 1 to 825 | exact | | | 825/825 (100 %) | 0 diff (100 %id) |
CR624621 | Placenta Cot 25-normalized | .c | 53 to 882 | 1 to 830 | exact | | | 830/830 (100 %) | 0 diff (100 %id) |
AL544182 | placenta, Placenta Cot 25-normalized | .c | 53 to 877 | 1 to 825 | exact | fully sequenced, | | 825/825 (100 %) | 6 diff (99.3 %id) |
AL545302 | placenta, Placenta Cot 25-normalized | .c | 53 to 877 | 1 to 825 | exact | fully sequenced, | | 825/825 (100 %) | 0 diff (100 %id) |
AL552728 | placenta, Placenta Cot 25-normalized | .c | 53 to 882 | 1 to 830 | exact | fully sequenced, | | 830/830 (100 %) | 0 diff (100 %id) |
AL561328 | B cells from Burkitt lymphoma | .c | 53 to 860 | 1 to 807 | F16X | fully sequenced, | | 807/807 (100 %) | 1 diff (99.9 %id) |
BU177672 | melanotic melanoma, cell line, skin | .c | 53 to 877 | 32 to 859 | exact | | | 828/943 (87 %) | 15 diff (98.5 %id) |
TI_57175934 | | .c | 53 to 876 | 27 to 847 | exact | | | 821/855 (96 %) | 11 diff (98.8 %id) |
BM697501 | eye, fetal eyes | .c | 53 to 679 | 1 to 627 | exact | fully sequenced, | | 627/627 (100 %) | 0 diff (100 %id) |
BU195886 | melanotic melanoma, cell line, skin | .c | 54 to 872 | 1 to 828 | exact | | | 828/920 (90 %) | 10 diff (99.0 %id) |
BU151547 | melanotic melanoma, cell line, skin | .c | 54 to 877 | 1 to 825 | exact | | | 825/832 (99 %) | 3 diff (99.7 %id) |
BU177733 | melanotic melanoma, cell line, skin | .c | 54 to 877 | 1 to 828 | exact | | | 828/834 (99 %) | 6 diff (99.3 %id) |
BQ683161 | melanotic melanoma, cell line, skin | .c | 54 to 875 | 1 to 828 | exact | | | 828/925 (89 %) | 11 diff (98.9 %id) |
BQ890538 | melanotic melanoma, cell line, skin | .c | 54 to 834 | 1 to 794 | exact | | | 794/968 (82 %) | 18 diff (98.2 %id) |
CD107761 | brain, Pituitary | .c | 54 to 875 | 23 to 847 | R34G | AAA | | 825/847 (97 %) | 20 diff (97.7 %id) |
BG110951 | Bone, osteosarcoma, cell line | .c | 56 to 868 | 1 to 809 | exact | | | 809/822 (98 %) | 24 diff (97.1 %id) |
BG166241 | hypernephroma, cell line, Kidney | .c | 56 to 875 | 1 to 820 | W52G L53* | | | 820/843 (97 %) | 30 diff (96.5 %id) |
BI763465 | pooled colon, kidney, stomach | .c | 56 to 882 | 1 to 828 | exact | | | 828/851 (97 %) | 7 diff (99.2 %id) |
TI_57150458 | | .c | 56 to 877 | 64 to 875 | A2R Y3I H4T G5A L6H ... | | | 812/886 (91 %) | 15 diff (98.4 %id) |
TI_57233628 | | .c | 56 to 483 | 37 to 470 | exact | | | 434/472 (91 %) | 13 diff (97.3 %id) |
W17245 | lung | .c | 57 to 481 | 1 to 421 | exact | fully sequenced, | | 421/421 (100 %) | 4 diff (99.1 %id) |
BU157632 | ductal carcinoma, cell line, Pancreas | .c | 57 to 875 | 1 to 819 | exact | AAA | | 819/819 (100 %) | 4 diff (99.6 %id) |
BU191382 | ductal carcinoma, cell line, Pancreas | .c | 57 to 877 | 1 to 820 | exact | | | 820/824 (99 %) | 7 diff (99.2 %id) |
AA348637 | brain, hippocampus | .c | 58 to 341 | 1 to 284 | | | | 284/284 (100 %) | 0 diff (100 %id) |
CN483743 | eye | .c | 58 to 678 | 1 to 621 | exact | | | 621/621 (100 %) | 0 diff (100 %id) |
BG476518 | melanotic melanoma, skin | .c | 58 to 869 | 1 to 811 | L41X F51X | AAA | | 811/811 (100 %) | 11 diff (98.7 %id) |
BQ431685 | melanotic melanoma, skin | .c | 58 to 874 | 1 to 822 | exact | | | 822/901 (91 %) | 9 diff (99.1 %id) |
CF127008 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 58 to 843 | 1 to 782 | exact | | | 782/782 (100 %) | 5 diff (99.4 %id) |
TI_154190103 | | .c | 58 to 874 | 51 to 859 | exact | AAA | | 809/809 (100 %) | 9 diff (98.9 %id) |
BI829580 | brain, medulla | .c | 59 to 876 | 1 to 816 | exact | | | 816/824 (99 %) | 5 diff (99.4 %id) |
BM452082 | melanotic melanoma, skin | .c | 59 to 874 | 13 to 828 | exact | AAA | | 816/828 (98 %) | 14 diff (98.4 %id) |
BQ230822 | epithelioid carcinoma, Pancreas | .c | 60 to 870 | 1 to 812 | exact | AAA | | 812/812 (100 %) | 3 diff (99.7 %id) |
BU855620 | ovary, teratocarcinoma, cell line | .c | 60 to 877 | 37 to 855 | exact | | | 819/856 (95 %) | 9 diff (99.0 %id) |
BM691583 | eye, RPE and Choroid | .c | 60 to 500 | 1 to 441 | exact | fully sequenced, | | 441/441 (100 %) | 4 diff (99.1 %id) |
BG478640 | melanotic melanoma, skin | .c | 61 to 834 | 1 to 779 | E71K | AAA | | 779/833 (93 %) | 14 diff (98.4 %id) |
BI825653 | brain, medulla | .c | 61 to 877 | 1 to 827 | exact | | | 827/852 (97 %) | 14 diff (98.4 %id) |
BQ233773 | epithelioid carcinoma, Pancreas | .c | 61 to 877 | 1 to 825 | exact | | | 825/928 (88 %) | 24 diff (97.5 %id) |
BU601972 | mixed (pool of 40 RNAs) | .c | 61 to 876 | 1 to 828 | V42L | | | 828/854 (96 %) | 28 diff (96.8 %id) |
TI_57170715 | | .c | 61 to 877 | 69 to 895 | exact | | | 827/920 (89 %) | 20 diff (97.9 %id) |
CV573780 | cornea, eye | .c | 61 to 671 | 1 to 611 | exact | | | 611/611 (100 %) | 0 diff (100 %id) |
BM694259 | eye, RPE and Choroid | .c | 61 to 338 | 1 to 278 | | | | 278/278 (100 %) | 1 diff (99.7 %id) |
CR623335 | Placenta Cot 25-normalized | .c | 62 to 877 | 1 to 816 | exact | | | 816/816 (100 %) | 0 diff (100 %id) |
BX360371 | Placenta Cot 25-normalized | .c | 62 to 877 | 1 to 817 | F16S | | | 817/817 (100 %) | 2 diff (99.8 %id) |
BM555820 | amelanotic melanoma, cell line, skin | .c | 62 to 877 | 1 to 815 | exact | AAA | | 815/1171 (69 %) | 13 diff (98.9 %id) |
BF378759 | uterus | .c | 63 to 313 | 259 to 9 | | | | 251/278 (90 %) | 0 diff (100 %id) |
BX344227 | Placenta Cot 25-normalized | .c | 63 to 839 | 777 to 1 | G5X Q59R I73L | | | 777/777 (100 %) | 10 diff (98.8 %id) |
BQ641386 | eye, normal pigmented retinal epithelium | .c | 63 to 882 | 1 to 824 | exact | | | 824/888 (92 %) | 12 diff (98.7 %id) |
BU542082 | carcinoma, cell line, Prostate | .c | 63 to 875 | 1 to 818 | exact | AAA | | 818/818 (100 %) | 11 diff (98.7 %id) |
BM311863 | Pancreas, Purified pancreatic islet | .c | 64 to 651 | 1 to 588 | exact | | | 588/588 (100 %) | 0 diff (100 %id) |
BI161214 | epithelioid carcinoma cell line, Pancreas | .c | 64 to 868 | 1 to 809 | exact | | | 809/874 (92 %) | 14 diff (98.4 %id) |
BU167733 | eye, retinoblastoma | .c | 64 to 875 | 1 to 823 | exact | AAA | | 823/823 (100 %) | 16 diff (98.1 %id) |
BQ938017 | leiomyosarcoma, uterus | .c | 64 to 875 | 1 to 821 | exact | AAA | | 821/821 (100 %) | 14 diff (98.3 %id) |
CF128063 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 64 to 653 | 1 to 590 | exact | | | 590/590 (100 %) | 0 diff (100 %id) |
TI_154193883 | | .c | 64 to 874 | 50 to 856 | exact | | | 807/812 (99 %) | 18 diff (97.8 %id) |
AA310149 | | .c | 66 to 526 | 1 to 461 | C47X | | | 461/461 (100 %) | 0 diff (100 %id) |
FN052554 | breast carcinoma | .c | 66 to 138 | 1 to 75 | | | | 75/75 (100 %) | 3 diff (96.0 %id) |
FN052688 | breast carcinoma | .c | 66 to 138 | 1 to 75 | | | | 75/75 (100 %) | 3 diff (96.0 %id) |
FN055324 | breast carcinoma | .c | 66 to 138 | 1 to 73 | | | | 73/73 (100 %) | 1 diff (98.7 %id) |
FN076003 | breast carcinoma | .c | 66 to 138 | 1 to 75 | | | | 75/75 (100 %) | 2 diff (97.4 %id) |
BE784767 | large cell carcinoma, lung | .c | 66 to 852 | 1 to 786 | W52G L53* | AAA | | 786/800 (98 %) | 15 diff (98.2 %id) |
CN400092 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 67 to 649 | 1 to 583 | exact | | | 583/583 (100 %) | 0 diff (100 %id) |
BM510339 | insulinoma, Pancreas | .c | 67 to 507 | 7 to 447 | exact | fully sequenced, | | 441/447 (98 %) | 7 diff (98.5 %id) |
BM511061 | insulinoma, Pancreas | .c | 67 to 585 | 7 to 525 | exact | | | 519/525 (98 %) | 7 diff (98.7 %id) |
CK823749 | insulinoma, Pancreas | .c | 67 to 632 | 7 to 572 | exact | | | 566/572 (98 %) | 7 diff (98.8 %id) |
BQ130397 | insulinoma, Pancreas | .c | 67 to 540 | 7 to 480 | exact | fully sequenced, | | 474/480 (98 %) | 9 diff (98.2 %id) |
BQ581160 | insulinoma, Pancreas | .c | 67 to 284 | 7 to 224 | | fully sequenced, | | 218/224 (97 %) | 6 diff (97.4 %id) |
BM875574 | insulinoma, Pancreas | .c | 69 to 414 | 1 to 346 | exact | fully sequenced, | | 346/346 (100 %) | 4 diff (98.9 %id) |
CB139354 | Liver | .c | 69 to 555 | 1 to 487 | exact | | | 487/487 (100 %) | 0 diff (100 %id) |
BG573467 | placenta | .c | 70 to 870 | 1 to 808 | W52G L53* | AAA | | 808/808 (100 %) | 22 diff (97.3 %id) |
BM876388 | insulinoma, Pancreas | .c | 71 to 414 | 7 to 350 | exact | fully sequenced, | | 344/350 (98 %) | 6 diff (98.3 %id) |
AW839415 | leiomios | .c | 72 to 284 | 213 to 1 | | | | 213/214 (99 %) | 1 diff (99.6 %id) |
ES314418 | occipital scalp hair, skin | .c | 72 to 235 | 1 to 164 | | | | 164/164 (100 %) | 0 diff (100 %id) |
BP276626 | Kidney | .c | 72 to 653 | 1 to 582 | exact | | | 582/582 (100 %) | 0 diff (100 %id) |
TI_154193494 | | .c | 72 to 688 | 40 to 656 | exact | | | 617/628 (98 %) | 2 diff (99.7 %id) |
TI_154047960 | | .c | 73 to 874 | 887 to 95 | A2I Y3T H4P G5H L6C ... | AAA | | 793/963 (82 %) | 21 diff (97.9 %id) |
BG571488 | placenta | .c | 74 to 869 | 1 to 803 | exact | | | 803/849 (94 %) | 21 diff (97.6 %id) |
BE619900 | large cell carcinoma, lung | .c | 75 to 812 | 740 to 1 | F16L W17L F19L V20R G21R ... | | | 740/740 (100 %) | 6 diff (99.2 %id) |
BG831863 | epithelioid carcinoma cell line, Pancreas | .c | 75 to 875 | 1 to 805 | L23W V24C P25L W26V F27H ... | | | 805/866 (92 %) | 12 diff (98.7 %id) |
CA778168 | Pancreas, Purified pancreatic islet | .c | 75 to 876 | 6 to 807 | exact | fully sequenced, | | 802/807 (99 %) | 6 diff (99.3 %id) |
BE619287 | large cell carcinoma, lung | .c | 76 to 799 | 1 to 720 | I11X L41* | | | 720/769 (93 %) | 24 diff (96.9 %id) |
AA186399 | | .c | 77 to 562 | 1 to 484 | exact | fully sequenced, | | 484/484 (100 %) | 2 diff (99.6 %id) |
TI_57176643 | | .c | 78 to 877 | 52 to 844 | L6S T7L V8C P9L L10S ... | AAA | | 793/884 (89 %) | 19 diff (97.9 %id) |
CN400097 | embryonic stem cells, DMSO-treated H9 cellline | .c | 80 to 800 | 1 to 721 | exact | | | 721/721 (100 %) | 0 diff (100 %id) |
ES314687 | occipital scalp hair, skin | .c | 80 to 263 | 1 to 183 | | | | 183/203 (90 %) | 7 diff (96.6 %id) |
FN137831 | breast carcinoma | .c | 81 to 138 | 1 to 58 | | | | 58/58 (100 %) | 2 diff (96.6 %id) |
BQ061851 | lymph, lymphoma, cell line | .c | 82 to 875 | 1 to 797 | exact | AAA | | 797/797 (100 %) | 5 diff (99.4 %id) |
BQ065637 | lymph, lymphoma, cell line | .c | 82 to 875 | 1 to 794 | exact | AAA | | 794/794 (100 %) | 2 diff (99.8 %id) |
BU170725 | eye, retinoblastoma | .c | 82 to 874 | 1 to 806 | exact | AAA | | 806/806 (100 %) | 13 diff (98.4 %id) |
BU197382 | eye, retinoblastoma | .c | 82 to 874 | 1 to 798 | exact | AAA | | 798/798 (100 %) | 7 diff (99.2 %id) |
BI829958 | brain, medulla | .c | 83 to 877 | 1 to 788 | L6S T7L V8C P9L L10S ... | AAA | | 788/828 (95 %) | 14 diff (98.4 %id) |
BM510336 | insulinoma, Pancreas | .c | 84 to 524 | 8 to 448 | L6V | | | 441/448 (98 %) | 6 diff (98.7 %id) |
BF750759 | breast_normal | .c | 85 to 259 | 182 to 1 | | | Submitted on the opposite strand | 188/182 (103 %) | 63 diff (65.4 %id) |
BM832138 | stomach | .c | 96 to 327 | 1 to 232 | | | | 232/232 (100 %) | 0 diff (100 %id) |
BM716385 | eye, RPE and Choroid | .c | 96 to 414 | 1 to 319 | exact | fully sequenced, | | 319/319 (100 %) | 0 diff (100 %id) |
CR456856 | | .c | 102 to 345 | 1 to 244 | | | | 244/246 (99 %) | 1 diff (99.6 %id) |
CR542131 | | .c | 102 to 344 | 1 to 243 | | | | 243/243 (100 %) | 0 diff (100 %id) |
CA940995 | Pancreas, Purified pancreatic islet | .c | 102 to 414 | 1 to 313 | exact | fully sequenced, | | 313/313 (100 %) | 0 diff (100 %id) |
FN143170 | breast carcinoma | .c | 108 to 205 | 102 to 7 | | | Submitted on the opposite strand | 96/105 (91 %) | 2 diff (98.1 %id) |
AI752251 | Bone, Hip | .c | 109 to 559 | 18 to 468 | | | | 451/468 (96 %) | 6 diff (98.8 %id) |
TI_154097918 | | .c | 112 to 869 | 850 to 91 | | AAA | | 760/1156 (65 %) | 69 diff (94.1 %id) |
AW373904 | breast | .c | 113 to 794 | 684 to 6 | | | | 679/684 (99 %) | 3 diff (99.6 %id) |
AW373941 | breast | .c | 113 to 794 | 684 to 6 | | | | 679/684 (99 %) | 3 diff (99.6 %id) |
CA775333 | Pancreas, Purified pancreatic islet | .c | 116 to 342 | 227 to 1 | | | | 227/229 (99 %) | 14 diff (93.9 %id) |
TI_154061696 | | .c | 119 to 874 | 844 to 98 | | AAA | | 747/909 (82 %) | 17 diff (98.2 %id) |
TI_149279669 | | .c | 122 to 874 | 832 to 85 | | AAA | | 748/1127 (66 %) | 21 diff (98.2 %id) |
CA941986 | Pancreas, Purified pancreatic islet | .c | 123 to 633 | 1 to 511 | | | | 511/511 (100 %) | 0 diff (100 %id) |
BM713386 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 132 to 284 | 1 to 153 | | fully sequenced, | | 153/153 (100 %) | 0 diff (100 %id) |
BU856134 | ovary, teratocarcinoma, cell line | .c | 136 to 874 | 780 to 35 | | AAA | Submitted on the opposite strand | 746/911 (81 %) | 19 diff (98.0 %id) |
AW867857 | stomach_normal | .c | 139 to 738 | 624 to 26 | | | | 599/624 (95 %) | 0 diff (100 %id) |
AW390777 | stomach | .c | 140 to 433 | 295 to 3 | | | | 293/299 (97 %) | 2 diff (99.4 %id) |
TI_154110364 | | .c | 152 to 874 | 796 to 77 | | AAA | | 720/912 (78 %) | 4 diff (99.6 %id) |
AA039913 | uterus | .c | 153 to 495 | 1 to 343 | | fully sequenced, | | 343/343 (100 %) | 0 diff (100 %id) |
TI_154043207 | | .c | 167 to 874 | 802 to 98 | | AAA | | 705/950 (74 %) | 7 diff (99.3 %id) |
AA384943 | thyroid gland | .c | 172 to 525 | 1 to 354 | | | | 354/354 (100 %) | 0 diff (100 %id) |
TI_149288932 | | .c | 175 to 874 | 784 to 85 | | AAA | | 700/712 (98 %) | 4 diff (99.5 %id) |
CD367773 | Alveolar Macrophage, lung | .c | 180 to 874 | 713 to 19 | | AAA | | 695/695 (100 %) | 0 diff (100 %id) |
CA448104 | Chondrosarcoma, Left Pubic Bone | .c | 205 to 874 | 688 to 19 | | AAA | | 670/717 (93 %) | 1 diff (99.9 %id) |
CA411663 | Knee, Osteoarthritic Cartilage | .c | 206 to 874 | 686 to 19 | | AAA | | 668/668 (100 %) | 0 diff (100 %id) |
FN083285 | breast carcinoma | .c | 208 to 302 | 93 to 1 | | | Submitted on the opposite strand | 93/105 (88 %) | 2 diff (98.1 %id) |
TI_149278151 | | .c | 209 to 874 | 761 to 96 | | AAA | | 666/683 (97 %) | 5 diff (99.3 %id) |
CA427875 | Bone, Subchondral Bone | .c | 209 to 874 | 684 to 19 | | AAA | | 666/678 (98 %) | 0 diff (100 %id) |
BF896115 | marrow | .c | 210 to 352 | 173 to 31 | | | Submitted on the opposite strand | 143/173 (82 %) | 0 diff (100 %id) |
BU681504 | lung | .c | 211 to 874 | 682 to 19 | | AAA | | 664/664 (100 %) | 0 diff (100 %id) |
BE698407 | uterus_tumor | .c | 220 to 415 | 196 to 1 | | | | 196/200 (98 %) | 3 diff (98.5 %id) |
AW997822 | breast_normal | .c | 222 to 695 | 481 to 6 | | | Submitted on the opposite strand | 476/481 (98 %) | 1 diff (99.8 %id) |
AL544160 | placenta, Placenta Cot 25-normalized | .c | 223 to 842 | 620 to 1 | | fully sequenced, | | 620/620 (100 %) | 3 diff (99.6 %id) |
AL545449 | placenta, Placenta Cot 25-normalized | .c | 223 to 806 | 584 to 1 | | fully sequenced, | | 584/584 (100 %) | 15 diff (97.5 %id) |
AL552884 | placenta, Placenta Cot 25-normalized | .c | 223 to 822 | 600 to 1 | | fully sequenced, | | 600/600 (100 %) | 0 diff (100 %id) |
AL561311 | B cells from Burkitt lymphoma | .c | 223 to 837 | 617 to 1 | | fully sequenced, | | 617/617 (100 %) | 10 diff (98.4 %id) |
BQ549331 | insulinoma, Pancreas | .c | 223 to 874 | 667 to 16 | | fully sequenced, AAA | | 652/652 (100 %) | 1 diff (99.9 %id) |
BM674721 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 223 to 874 | 670 to 19 | | fully sequenced, AAA | | 652/652 (100 %) | 0 diff (100 %id) |
TI_157612895 | | .c | 250 to 874 | 735 to 109 | | AAA | | 627/749 (83 %) | 36 diff (95.2 %id) |
AL048383 | uterus | .c | 254 to 882 | 655 to 21 | | AAA | | 635/708 (89 %) | 18 diff (97.5 %id) |
EC481332 | Prostate | .c | 254 to 339 | 96 to 12 | | | | 85/102 (83 %) | 0 diff (100 %id) |
AI924148 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .c | 254 to 875 | 622 to 1 | | | | 622/675 (92 %) | 2 diff (99.8 %id) |
BM510808 | insulinoma, Pancreas | .c | 254 to 874 | 637 to 17 | | AAA | | 621/626 (99 %) | 1 diff (99.9 %id) |
TI_154038911 | | .c | 254 to 874 | 735 to 114 | | AAA | | 622/778 (79 %) | 9 diff (98.9 %id) |
AA130515 | | .c | 257 to 628 | 1 to 372 | | | | 372/372 (100 %) | 0 diff (100 %id) |
BE348371 | carcinoid, lung | .c | 257 to 829 | 1 to 573 | | | Submitted on the opposite strand | 573/573 (100 %) | 0 diff (100 %id) |
TI_149278507 | | .c | 260 to 869 | 753 to 143 | | AAA | | 611/703 (86 %) | 23 diff (96.8 %id) |
BM310455 | Pancreas, Purified pancreatic islet | .c | 273 to 883 | 611 to 1 | | tiling clone, | | 611/611 (100 %) | 0 diff (100 %id) |
ES308504 | beard hair, skin | .c | 273 to 465 | 1 to 193 | | | | 193/193 (100 %) | 0 diff (100 %id) |
FN154106 | breast carcinoma | .c | 275 to 336 | 1 to 62 | | | | 62/62 (100 %) | 2 diff (96.8 %id) |
AW878130 | ovary | .c | 277 to 519 | 242 to 1 | | | | 242/243 (99 %) | 9 diff (96.3 %id) |
AW888384 | nervous_tumor | .c | 283 to 668 | 384 to 1 | | | | 384/385 (99 %) | 15 diff (96.2 %id) |
AW839152 | leiomios | .c | 290 to 785 | 500 to 5 | | | | 496/500 (99 %) | 0 diff (100 %id) |
CA425294 | Bone, Subchondral Bone | .c | 296 to 874 | 597 to 19 | | AAA | | 579/579 (100 %) | 0 diff (100 %id) |
BM264033 | Pancreas, Purified pancreatic islet | .c | 297 to 877 | 581 to 1 | | | | 581/581 (100 %) | 0 diff (100 %id) |
EL946967 | eyeball | .c | 301 to 766 | 11 to 476 | | | | 466/476 (97 %) | 7 diff (98.6 %id) |
FN099762 | breast carcinoma | .c | 305 to 388 | 97 to 11 | | | Submitted on the opposite strand | 87/100 (87 %) | 0 diff (100 %id) |
EC567373 | Prostate | .c | 307 to 388 | 92 to 12 | | | | 81/93 (87 %) | 0 diff (100 %id) |
FN047059 | breast carcinoma | .c | 312 to 405 | 1 to 93 | | | | 93/93 (100 %) | 1 diff (99.0 %id) |
TI_154192039 | | .c | 320 to 874 | 51 to 607 | | AAA | | 557/557 (100 %) | 2 diff (99.7 %id) |
BU553462 | ovary, teratocarcinoma, cell line | .c | 322 to 874 | 594 to 35 | | AAA | Submitted on the opposite strand | 560/1114 (50 %) | 19 diff (98.3 %id) |
TI_149272652 | | .c | 322 to 874 | 638 to 86 | | AAA | | 553/971 (56 %) | 0 diff (100 %id) |
BU675233 | lung, Primary Lung Epithelial Cells | .c | 322 to 874 | 571 to 19 | | AAA | | 553/561 (98 %) | 0 diff (100 %id) |
EC448734 | Prostate | .c | 338 to 432 | 96 to 1 | | | | 96/96 (100 %) | 3 diff (96.9 %id) |
EC470648 | Prostate | .c | 338 to 429 | 97 to 6 | | | | 92/97 (94 %) | 0 diff (100 %id) |
EC486002 | Prostate | .c | 338 to 430 | 100 to 5 | | | | 96/100 (96 %) | 0 diff (100 %id) |
AA916011 | adenocarcinoma, colon | .c | 346 to 874 | 529 to 1 | | | | 529/529 (100 %) | 0 diff (100 %id) |
AI304358 | adenocarcinoma, colon | .c | 346 to 869 | 524 to 1 | | | | 524/524 (100 %) | 0 diff (100 %id) |
BM875327 | insulinoma, Pancreas | .c | 353 to 874 | 538 to 16 | | fully sequenced, AAA | | 523/523 (100 %) | 2 diff (99.7 %id) |
BM876133 | insulinoma, Pancreas | .c | 353 to 874 | 538 to 16 | | fully sequenced, AAA | | 523/523 (100 %) | 2 diff (99.7 %id) |
CA777899 | Pancreas, Purified pancreatic islet | .c | 353 to 860 | 508 to 1 | | fully sequenced, | | 508/508 (100 %) | 4 diff (99.3 %id) |
CA866017 | Pancreas, Purified pancreatic islet | .c | 353 to 874 | 522 to 1 | | fully sequenced, | | 522/522 (100 %) | 0 diff (100 %id) |
BU734329 | eye, RPE and Choroid | .c | 353 to 874 | 540 to 19 | | fully sequenced, AAA | | 522/522 (100 %) | 0 diff (100 %id) |
BF942400 | medullary carcinoma, thyroid | .c | 362 to 789 | 1 to 428 | | | Submitted on the opposite strand | 428/428 (100 %) | 0 diff (100 %id) |
AA282619 | germinal center B cell | .c | 363 to 860 | 1 to 497 | | fully sequenced, | | 497/497 (100 %) | 2 diff (99.6 %id) |
BI043411 | ovary | .c | 377 to 730 | 357 to 3 | | | | 355/372 (95 %) | 0 diff (100 %id) |
TI_154024210 | | .c | 380 to 874 | 581 to 85 | | AAA | | 497/706 (70 %) | 6 diff (99.2 %id) |
BM716235 | eye, optic nerve | .c | 384 to 873 | 1 to 489 | | fully sequenced, | | 489/489 (100 %) | 2 diff (99.6 %id) |
CF130793 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 394 to 874 | 1 to 481 | | AAA | | 481/481 (100 %) | 0 diff (100 %id) |
TI_154192819 | | .c | 394 to 874 | 52 to 532 | | AAA | | 481/481 (100 %) | 0 diff (100 %id) |
AW950201 | | .c | 395 to 874 | 1 to 480 | | AAA | | 480/480 (100 %) | 0 diff (100 %id) |
BG057633 | blood, lymphocyte | .c | 395 to 875 | 481 to 1 | | | | 481/481 (100 %) | 0 diff (100 %id) |
TI_154094777 | | .c | 396 to 874 | 590 to 112 | | AAA | | 479/1246 (38 %) | 10 diff (99.2 %id) |
GD158933 | | .c | 397 to 874 | 1 to 478 | | AAA | | 478/478 (100 %) | 12 diff (97.5 %id) |
BP871499 | embryonal kidney | .c | 409 to 740 | 332 to 1 | | | Submitted on the opposite strand | 332/332 (100 %) | 0 diff (100 %id) |
BM707463 | eye, eye anterior segment | .c | 409 to 874 | 510 to 45 | | AAA | Submitted on the opposite strand | 466/466 (100 %) | 2 diff (99.6 %id) |
FN125360 | breast carcinoma | .c | 411 to 480 | 1 to 72 | | | | 72/73 (98 %) | 3 diff (95.9 %id) |
FN138635 | breast carcinoma | .c | 415 to 478 | 1 to 63 | | | | 63/64 (98 %) | 3 diff (95.4 %id) |
FN163641 | breast carcinoma | .c | 423 to 537 | 115 to 1 | | | Submitted on the opposite strand | 115/115 (100 %) | 0 diff (100 %id) |
FN049036 | breast carcinoma | .c | 424 to 518 | 1 to 95 | | | | 95/96 (98 %) | 1 diff (99.0 %id) |
AI075464 | breast | .c | 424 to 876 | 453 to 1 | | | | 453/453 (100 %) | 0 diff (100 %id) |
AI523440 | aorta | .c | 425 to 870 | 446 to 1 | | | | 446/446 (100 %) | 0 diff (100 %id) |
BF087222 | head_neck | .c | 426 to 705 | 291 to 5 | | | | 287/293 (97 %) | 0 diff (100 %id) |
FN112547 | breast carcinoma | .c | 430 to 536 | 1 to 104 | | | | 104/106 (98 %) | 5 diff (95.3 %id) |
DB558665 | hypothalamus | .c | 431 to 874 | 1 to 444 | | | Submitted on the opposite strand | 444/444 (100 %) | 0 diff (100 %id) |
FN119775 | breast carcinoma | .c | 432 to 534 | 102 to 2 | | | Submitted on the opposite strand | 101/106 (95 %) | 0 diff (100 %id) |
FN171526 | breast carcinoma | .c | 436 to 546 | 112 to 1 | | | Submitted on the opposite strand | 112/112 (100 %) | 3 diff (97.4 %id) |
FN159051 | breast carcinoma | .c | 439 to 543 | 102 to 1 | | | Submitted on the opposite strand | 102/103 (99 %) | 5 diff (95.2 %id) |
AA633008 | lung, lung tumor | .c | 445 to 881 | 443 to 7 | | | | 437/443 (98 %) | 0 diff (100 %id) |
N32223 | placenta | .c | 448 to 877 | 436 to 4 | | | | 433/436 (99 %) | 0 diff (100 %id) |
AA601547 | breast | .c | 459 to 874 | 432 to 17 | | AAA | | 416/416 (100 %) | 0 diff (100 %id) |
AA614559 | breast | .c | 460 to 874 | 434 to 20 | | AAA | | 415/415 (100 %) | 0 diff (100 %id) |
AA041536 | uterus | .c | 465 to 874 | 439 to 29 | | fully sequenced, AAA | | 411/411 (100 %) | 0 diff (100 %id) |
AI289201 | 2 pooled tumors (clear cell type), Kidney | .c | 465 to 877 | 413 to 1 | | | | 413/413 (100 %) | 0 diff (100 %id) |
AA622323 | Prostate, prostate tumor | .c | 466 to 874 | 429 to 21 | | AAA | | 409/409 (100 %) | 0 diff (100 %id) |
BM662227 | eye, RPE and Choroid | .c | 470 to 870 | 416 to 18 | | fully sequenced, AAA | | 399/399 (100 %) | 2 diff (99.5 %id) |
BF940497 | fibrotheoma, ovary | .c | 473 to 877 | 405 to 1 | | | | 405/405 (100 %) | 0 diff (100 %id) |
BU733131 | eye, RPE and Choroid | .c | 473 to 874 | 420 to 19 | | AAA | | 402/402 (100 %) | 0 diff (100 %id) |
N89767 | lung | .c | 475 to 874 | 400 to 1 | | fully sequenced, | | 400/400 (100 %) | 3 diff (99.3 %id) |
EC539820 | Prostate | .c | 477 to 585 | 109 to 1 | | | | 109/109 (100 %) | 0 diff (100 %id) |
BM508157 | insulinoma, Pancreas | .c | 477 to 874 | 414 to 17 | | fully sequenced, AAA | | 398/398 (100 %) | 0 diff (100 %id) |
AI752252 | Bone, Hip | .c | 479 to 874 | 424 to 29 | | AAA | | 396/396 (100 %) | 0 diff (100 %id) |
AA505533 | breast | .c | 482 to 875 | 394 to 1 | | | | 394/394 (100 %) | 0 diff (100 %id) |
BU949563 | Pancreas, Purified pancreatic islet | .c | 484 to 877 | 394 to 1 | | fully sequenced, | | 394/394 (100 %) | 0 diff (100 %id) |
BU951937 | Pancreas, Purified pancreatic islet | .c | 484 to 877 | 394 to 1 | | fully sequenced, | | 394/394 (100 %) | 0 diff (100 %id) |
FN174913 | breast carcinoma | .c | 485 to 593 | 1 to 109 | | | | 109/109 (100 %) | 2 diff (98.2 %id) |
BU951872 | Pancreas, Purified pancreatic islet | .c | 485 to 877 | 393 to 1 | | fully sequenced, | | 393/393 (100 %) | 0 diff (100 %id) |
FN070616 | breast carcinoma | .c | 488 to 548 | 1 to 62 | | | | 62/63 (98 %) | 2 diff (96.9 %id) |
FN068190 | breast carcinoma | .c | 490 to 579 | 86 to 1 | | | Submitted on the opposite strand | 86/90 (95 %) | 7 diff (92.3 %id) |
EC550266 | Prostate | .c | 492 to 602 | 1 to 111 | | | | 111/111 (100 %) | 7 diff (93.7 %id) |
AI081637 | liver and spleen | .c | 494 to 874 | 381 to 1 | | | | 381/381 (100 %) | 0 diff (100 %id) |
BF885040 | testis_normal | .c | 496 to 597 | 102 to 1 | | | Submitted on the opposite strand | 102/108 (94 %) | 7 diff (93.6 %id) |
BQ286134 | Pancreas, Purified pancreatic islet | .c | 499 to 869 | 371 to 1 | | fully sequenced, | | 371/371 (100 %) | 0 diff (100 %id) |
FN135445 | breast carcinoma | .c | 501 to 604 | 1 to 104 | | | | 104/105 (99 %) | 4 diff (96.2 %id) |
BQ130144 | insulinoma, Pancreas | .c | 510 to 874 | 376 to 12 | | fully sequenced, AAA | | 365/365 (100 %) | 6 diff (98.4 %id) |
FN173143 | breast carcinoma | .c | 511 to 613 | 101 to 1 | | | Submitted on the opposite strand | 101/101 (100 %) | 2 diff (98.1 %id) |
AW264461 | brain, three pooled meningiomas | .c | 519 to 876 | 358 to 1 | | | | 358/358 (100 %) | 0 diff (100 %id) |
BM999028 | lung, Lung Focal Fibrosis | .c | 520 to 874 | 2 to 355 | | AAA | Submitted on the opposite strand | 354/355 (99 %) | 6 diff (98.4 %id) |
AA302536 | aorta | .c | 522 to 870 | 1 to 349 | | | | 349/349 (100 %) | 0 diff (100 %id) |
FN048600 | breast carcinoma | .c | 522 to 627 | 1 to 106 | | | | 106/106 (100 %) | 0 diff (100 %id) |
AA514933 | breast | .c | 524 to 874 | 384 to 34 | | AAA | | 351/351 (100 %) | 0 diff (100 %id) |
AA420655 | | .c | 527 to 870 | 377 to 34 | | AAA | | 344/344 (100 %) | 2 diff (99.5 %id) |
AI302572 | 2 pooled tumors (clear cell type), Kidney | .c | 528 to 874 | 357 to 11 | | AAA | | 347/347 (100 %) | 0 diff (100 %id) |
BQ377841 | uterus | .c | 530 to 747 | 217 to 1 | | | | 217/227 (95 %) | 6 diff (97.4 %id) |
AA181863 | | .c | 532 to 880 | 352 to 1 | | fully sequenced, | | 352/352 (100 %) | 3 diff (99.2 %id) |
BU163967 | epithelioid carcinoma, Pancreas | .c | 534 to 874 | 1 to 341 | | AAA | | 341/341 (100 %) | 0 diff (100 %id) |
AA877076 | Kidney | .c | 536 to 877 | 342 to 1 | | | | 342/342 (100 %) | 0 diff (100 %id) |
AI601130 | colon | .c | 538 to 876 | 339 to 1 | | | | 339/339 (100 %) | 0 diff (100 %id) |
FN048071 | breast carcinoma | .c | 542 to 634 | 93 to 1 | | | Submitted on the opposite strand | 93/97 (95 %) | 0 diff (100 %id) |
FN068824 | breast carcinoma | .c | 546 to 620 | 74 to 1 | | | Submitted on the opposite strand | 74/76 (97 %) | 1 diff (98.7 %id) |
AI719145 | aorta | .c | 547 to 874 | 328 to 1 | | | | 328/328 (100 %) | 0 diff (100 %id) |
AA777332 | liver and spleen | .c | 548 to 874 | 327 to 1 | | | | 327/327 (100 %) | 0 diff (100 %id) |
AA584952 | germ cell tumor | .c | 550 to 881 | 350 to 19 | | AAA | | 332/332 (100 %) | 0 diff (100 %id) |
FN064123 | breast carcinoma | .c | 553 to 649 | 1 to 97 | | | | 97/97 (100 %) | 0 diff (100 %id) |
R15642 | | .c | 559 to 839 | 280 to 1 | | | | 280/280 (100 %) | 2 diff (99.3 %id) |
EC487915 | Prostate | .c | 571 to 660 | 8 to 97 | | | | 90/97 (92 %) | 6 diff (93.9 %id) |
AI971948 | fibrotheoma, ovary | .c | 578 to 877 | 300 to 1 | | | | 300/300 (100 %) | 0 diff (100 %id) |
CF527902 | placenta | .c | 584 to 874 | 308 to 18 | | AAA | | 291/291 (100 %) | 0 diff (100 %id) |
AI281859 | esophagus, squamous cell carcinoma | .c | 589 to 867 | 293 to 15 | | AAA | | 279/279 (100 %) | 0 diff (100 %id) |
DV460594 | cochlea, ear | .c | 602 to 869 | 290 to 23 | | AAA | Submitted on the opposite strand | 268/269 (99 %) | 0 diff (100 %id) |
FN100608 | breast carcinoma | .c | 606 to 682 | 77 to 1 | | | Submitted on the opposite strand | 77/78 (98 %) | 0 diff (100 %id) |
AA282532 | germinal center B cell | .c | 613 to 874 | 262 to 1 | | fully sequenced, | | 262/262 (100 %) | 0 diff (100 %id) |
W57564 | heart | .c | 623 to 874 | 252 to 1 | | | | 252/252 (100 %) | 0 diff (100 %id) |
AA369261 | placenta | .c | 624 to 874 | 251 to 1 | | | | 251/251 (100 %) | 0 diff (100 %id) |
AW376352 | colon | .c | 629 to 840 | 210 to 10 | | | | 201/211 (95 %) | 14 diff (93.4 %id) |
CN400093 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 633 to 874 | 1 to 242 | | AAA | | 242/242 (100 %) | 0 diff (100 %id) |
AA353172 | | .c | 635 to 874 | 240 to 1 | | | Submitted on the opposite strand | 240/240 (100 %) | 1 diff (99.6 %id) |
BG222075 | moderate to poorly differentiated invasivecarcinoma, tongue | .c | 636 to 874 | 307 to 69 | | AAA | | 239/243 (98 %) | 0 diff (100 %id) |
BU735698 | eye, fetal eyes | .c | 649 to 874 | 244 to 19 | | fully sequenced, AAA | | 226/226 (100 %) | 0 diff (100 %id) |
AI198465 | placenta | .c | 651 to 882 | 244 to 13 | | AAA | | 232/232 (100 %) | 0 diff (100 %id) |
AW118515 | brain, tumor, 5 pooled (see description) | .c | 665 to 869 | 220 to 16 | | AAA | | 205/205 (100 %) | 0 diff (100 %id) |
FN168021 | breast carcinoma | .c | 713 to 800 | 1 to 86 | | | | 86/94 (91 %) | 3 diff (96.9 %id) |
AA564471 | colon | .c | 718 to 874 | 174 to 18 | | AAA | | 157/157 (100 %) | 0 diff (100 %id) |
AI313293 | brain, oligodendroglioma | .c | 732 to 870 | 1 to 140 | | AAA | Submitted on the opposite strand | 140/140 (100 %) | 8 diff (94.3 %id) |
AW276680 | ovary, papillary serous carcinoma | .c | 732 to 861 | 1 to 131 | | | Submitted on the opposite strand | 131/131 (100 %) | 8 diff (93.9 %id) |
BE139210 | ovary, papillary serous carcinoma | .c | 732 to 861 | 1 to 131 | | | Submitted on the opposite strand | 131/131 (100 %) | 7 diff (94.7 %id) |
BE138404 | ovary, papillary serous carcinoma | .c | 732 to 873 | 1 to 143 | | | Submitted on the opposite strand | 143/143 (100 %) | 8 diff (94.5 %id) |
BE138411 | ovary, papillary serous carcinoma | .c | 732 to 869 | 1 to 139 | | | Submitted on the opposite strand | 139/139 (100 %) | 7 diff (95.0 %id) |
AI287950 | breast, invasive carcinoma | .c | 735 to 874 | 15 to 155 | | AAA | | 141/155 (90 %) | 6 diff (96.2 %id) |
AI348705 | adenocarcinoma, breast | .c | 735 to 872 | 15 to 153 | | AAA | Submitted on the opposite strand | 139/153 (90 %) | 6 diff (96.1 %id) |
AI307874 | adenocarcinoma, breast | .c | 735 to 872 | 16 to 153 | | AAA | Submitted on the opposite strand | 138/153 (90 %) | 6 diff (96.1 %id) |
AW071260 | bone marrow, stem cell 34+/38+ | .c | 735 to 869 | 12 to 147 | | | Submitted on the opposite strand | 136/147 (92 %) | 6 diff (96.0 %id) |
AW303185 | invasive adenocarcinoma, lung | .c | 735 to 873 | 15 to 154 | | | Submitted on the opposite strand | 140/154 (90 %) | 6 diff (96.2 %id) |
BF055815 | brain, oligodendroglioma | .c | 735 to 873 | 33 to 172 | | | | 140/172 (81 %) | 6 diff (96.6 %id) |
FN074777 | breast carcinoma | .c | 753 to 830 | 1 to 80 | | | | 80/98 (81 %) | 6 diff (93.9 %id) |
EC556464 | Prostate | .c | 767 to 872 | 107 to 4 | | | | 104/107 (97 %) | 0 diff (100 %id) |
FN062569 | breast carcinoma | .c | 770 to 869 | 1 to 99 | | | | 99/103 (96 %) | 2 diff (98.1 %id) |
EC488122 | Prostate | .c | 776 to 883 | 106 to 1 | | | | 106/106 (100 %) | 2 diff (98.2 %id) |
EC559564 | Prostate | .c | 776 to 883 | 108 to 3 | | | | 106/108 (98 %) | 0 diff (100 %id) |
BU733488 | eye, optic nerve | .c | 798 to 874 | 95 to 19 | | fully sequenced, AAA | | 77/77 (100 %) | 0 diff (100 %id) |
AV717561 | | .d | 1 to 718 | 1 to 718 | exact | tiling clone, | | 718/735 (97 %) | 9 diff (98.8 %id) |
BP196455 | adrenal gland | .d | 15 to 595 | 1 to 583 | exact | tiling clone, | | 583/587 (99 %) | 12 diff (98.0 %id) |
AA373131 | lung | .d | 30 to 355 | 1 to 326 | exact | | | 326/326 (100 %) | 1 diff (99.7 %id) |
AW955997 | | .d | 31 to 519 | 1 to 489 | exact | | | 489/494 (98 %) | 16 diff (96.8 %id) |
AW956001 | | .d | 31 to 580 | 1 to 550 | Y49C A57D | | | 550/560 (98 %) | 29 diff (94.9 %id) |
N28977 | melanocyte | .d | 40 to 359 | 1 to 326 | exact | fully sequenced, | | 326/326 (100 %) | 1 diff (99.7 %id) |
AI190609 | | .d | 117 to 723 | 625 to 19 | | AAA | | 607/607 (100 %) | 10 diff (98.4 %id) |
N20585 | melanocyte | .d | 329 to 718 | 390 to 1 | | tiling clone, fully sequenced, | | 390/390 (100 %) | 1 diff (99.8 %id) |
DB359569 | whole embryo, mainly body | .e-u | 1 to 445 | 534 to 97 | T8X K11X N13X | tiling clone, | | 438/541 (80 %) | 0 diff (100 %id) |
AW387797 | stomach | .e-u | 401 to 1046 | 655 to 12 | | tiling clone, | | 644/661 (97 %) | 0 diff (100 %id) |
AI288779 | carcinoid, lung | .e-u | 700 to 1208 | 508 to 1 | | tiling clone, | | 508/508 (100 %) | 6 diff (98.9 %id) |
DA624185 | Kidney | .e-u | 845 to 1394 | 2 to 551 | | tiling clone, capped | | 550/550 (100 %) | 0 diff (100 %id) |
AA063636 | heart | .e-u | 1247 to 1756 | 508 to 1 | | | | 508/572 (88 %) | 6 diff (99.0 %id) |
AA034230 | heart | .e-u | 1248 to 1757 | 1 to 508 | | | | 508/508 (100 %) | 2 diff (99.7 %id) |
AA931100 | Kidney | .e-u | 1283 to 1756 | 474 to 1 | | | | 474/474 (100 %) | 0 diff (100 %id) |
AW452681 | | .e-u | 1324 to 1764 | 458 to 18 | | tiling clone, AAA | | 441/441 (100 %) | 0 diff (100 %id) |
AW248037.
matches multiple genes | lung, small cell carcinoma | .e-u | 1427 to 1763 | 347 to 11 | | AAA | also hits gene varfar | 337/337 (100 %) | 0 diff (100 %id) |
AI479180 | Kidney | .e-u | 1472 to 1756 | 285 to 1 | | | | 285/285 (100 %) | 0 diff (100 %id) |
BM558315 | amelanotic melanoma, cell line, skin | .f | 1 to 770 | 1 to 775 | exact | tiling clone, AAA | | 775/775 (100 %) | 5 diff (99.4 %id) |
BM809437 | amelanotic melanoma, cell line, skin | .f | 2 to 771 | 1 to 775 | exact | AAA | | 775/775 (100 %) | 6 diff (99.3 %id) |
BU786518 | Pancreas, Purified pancreatic islet | .f | 3 to 435 | 1 to 433 | exact | fully sequenced, | | 433/433 (100 %) | 2 diff (99.6 %id) |
BE745892 | adenocarcinoma cell line, ovary | .f | 45 to 770 | 1 to 721 | L6S T7L V8C P9L L10S ... | AAA | | 721/721 (100 %) | 5 diff (99.4 %id) |
BU784781 | Pancreas, Purified pancreatic islet | .f | 405 to 771 | 367 to 1 | | tiling clone, fully sequenced, | | 367/367 (100 %) | 0 diff (100 %id) |
BU662889 | blood | .g-u | 1 to 628 | 12 to 640 | exact | tiling clone, | | 629/640 (98 %) | 6 diff (99.1 %id) |
GD153176 | | .g-u | 117 to 382 | 1 to 270 | | AAA | | 270/270 (100 %) | 8 diff (97.1 %id) |
AM055743 | | .g-u | 502 to 705 | 1 to 204 | | tiling clone, | | 204/204 (100 %) | 0 diff (100 %id) |
NR_002988.1 | | .g-u | 502 to 705 | 1 to 204 | | RefSeq, | | 204/204 (100 %) | 0 diff (100 %id) |
BX360370 | Placenta Cot 25-normalized | Gene ATP6V0E1andSNORA74B, variant not shown | | | | | This clone was ignored | | |
TI_149291856 | | Gene ATP6V0E1andSNORA74B, variant not shown | | | | AAA | This clone was ignored | | |
TI_149311121 | | Gene ATP6V0E1andSNORA74B, variant not shown | | | | | This clone was ignored | | |
TI_154100176 | | Gene ATP6V0E1andSNORA74B, variant not shown | | | | AAA | This clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a-u, .b, .c, .d, .e-u, .f, .g-u |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes DI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !